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Abstract
Protein methylation is one type of reversible post-translational modifications (PTMs), which plays vital roles in many cellular
processes such as transcription activity, DNA repair. Experimental identification of methylation sites on proteins without
prior knowledge is costly and time-consuming. In silico prediction of methylation sites might not only provide researches
with information on the candidate sites for further determination, but also facilitate to perform downstream
characterizations and site-specific investigations. In the present study, a novel approach based on Bi-profile Bayes feature
extraction combined with support vector machines (SVMs) was employed to develop the model for Prediction of Protein
Methylation Sites (BPB-PPMS) from primary sequence. Methylation can occur at many residues including arginine, lysine,
histidine, glutamine, and proline. For the present, BPB-PPMS is only designed to predict the methylation status for lysine
and arginine residues on polypeptides due to the absence of enough experimentally verified data to build and train
prediction models for other residues. The performance of BPB-PPMS is measured with a sensitivity of 74.71%, a specificity of
94.32% and an accuracy of 87.98% for arginine as well as a sensitivity of 70.05%, a specificity of 77.08% and an accuracy of
75.51% for lysine in 5-fold cross validation experiments. Results obtained from cross-validation experiments and test on
independent data sets suggest that BPB-PPMS presented here might facilitate the identification and annotation of protein
methylation. Besides, BPB-PPMS can be extended to build predictors for other types of PTM sites with ease. For public
access, BPB-PPMS is available at http://www.bioinfo.bio.cuhk.edu.hk/bpbppms.
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Introduction
Many proteins experience post-translational modifications
through which they present structural as well as functional diversity
and play important roles in many biological processes. Experimen-
tal identification and characterization of PTMs is labor-intensive
and expensive in the absence of prior knowledge concerning PTMs.
Computational prediction of PTM sites may provide researchers
with information on the candidate PTM sites for further
determination and downstream experimental characterizations.
Recently, protein methylation has attracted more and more
attentions with the identification of an growing number of
methyltransferases such as protein arginine methyltransferases
(PRMTs) [1–3], histone lysine methyltransferases (HKMTs)[4–6].
Two previous works were done for protein methylation site
prediction. Daily et al [7] built a predictor for arginine and lysine
methylation using SVMs based on the hypothesis that PTMs
preferentially occurs intrinsically disordered regions. They collected
positive training datasets (methylated sites) from SWISS-PROT
database (release 45)[8] and negative training datasets (non-
methylated sites) from the same proteins, which includeall arginines
and lysines not marked as methylated. Examples in training datasets
were encoded by a set of features including amino acid frequencies,
aromatic content, flexibility scalar, net charge, hydrophobic
moment, beta entropy, disorder information as well as PSI-BLAST
profiles. In another team, Chen et al. [9] constructed the first online
server MeMo for arginine and lysine methylation prediction via
SVMs strategy. Positive training datasets are composed of peptides
including the experimentally verified methylated lysines and
arginines from SWISS-PROT database (release 48) plus manually
curated data from PubMed literatures. Negative training datasets
were collected through the similar way described in previous works
[7,10]. Examples in training datasets were represented by
orthogonal binary coding scheme.
In the present study, a novel approach called Bi-profile Bayes was
theoretically developed to extract features from training datasets,
through which we constructed an online protein methylation
prediction tool BPB-PPMS based on SVMs algorithm. As for
encoding schemes (feature extraction approaches) employed in
works [7,9],eachtarget site wasrepresentedina singlefeature space
manner (such as either intrinsically disordered regions for
methylated peptide sequence or ordered regions for un-methylated
peptide sequence) or through fixed binary coding scheme (fixed
coding of each residue at any position for both methylated peptide
sequence and un-methylated peptide sequence). Theoretically, each
peptide sequence should exhibit different features in positive and
negative feature spaces, respectively. It would be more informative
to combine peptide sequence features in positive and negative
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scheme. Bi-profile Bayes defines positive (methylated) and negati-
ve(un-methylated) feature spaces based on known experimentally
verified data sets and each target site was represented in a bi-feature
space manner, which was encoded by positive and negative feature
vectors (see details in Methods). Results obtained from cross-
validation experiments and test on independent data sets indicate
the effectiveness of Bi-profile Bayes. BPB-PPMS is a novel general
arginine and lysine methylation online tool and can provide
probability information for prediction results other than that
provided by MeMo.
Methods
Data collection
Methylated sites and non-methylated sites were collected as
positive training datasets and negative training datasets, respec-
tively. The sliding window strategy was utilized to extract positive
and negative data from protein sequences as training data, which
were represented by peptide sequences with arginine and lysine
symmetrically surrounded by flanking residues. The positive
training dataset are composed of all the arginines and lysines
which were annotated as experimentally verified methylation on
proteins from SWISS-PROT database (release 56.1). The negative
training datasets include all the arginines and lysines that were not
marked by any methylation information on the same proteins, the
rational of which is that the resulting negative training samples are
more likely to be non-methylation sites than those obtained by
random as these proteins were experimentally investigated.
Candidate proteins for positive training datasets extraction were
retrieved by searching information containing ‘‘Omega-N-meth-
ylated arginine’’, ‘‘symmetric dimethylarginine’’, ‘‘Omega-N-
methylarginine’’ and ‘‘asymmetric dimethylarginine’’ for methyl-
ated arginines as well as ‘‘N6,N6,N6-trimethyllysine’’, ‘‘N6,N6-
dimethyllysine’’, ‘‘N6-mehtylated lysine’’ and ‘‘N6-methyllysine’’
for methylated lysines under the description field in the feature
table of Swiss-prot database. Total 363 candidate proteins
containing methylated arginines and 977 candidate proteins
containing methylated lysines were collected, respectively. Then,
experimentally verified methylated arginines and lysines were
recorded for later positive training datasets extraction by excluding
those annotated by ‘‘By similarity’’, ‘‘Potential’’ or ‘‘Probable’’ in
the description field. In total, this yielded a total of 434 peptide
sequences containing validated methylated arginines and 550
peptide sequences containing validated methylated lysines with
sliding window size 11(the optimal window size for both arginine
and lysine is 11 after several trials of 5, 7, 9, 11, 13, 15, 17 and data
information regarding other sliding window sizes not shown here),
respectively. Negative training datasets (non-methylated sites) for
arginine and lysine were collected from sequences which contain
experimentally validated methylated sites and included all
arginines and lysines which were not annotated by any
methylation information as described in previous studies[7,9,10].
Homology reduction and data refinement
Training datasets obtained through the way introduced in the
data collection section may present the homology and redundancy
to some extent, which will overestimate the performance of the
prediction model. Therefore, homology reduction or redundancy
elimination requires to be performed. The way of redundancy
elimination or homology reduction theoretically depends on the
form of input data during the process of training, which is either
the entire sequence or the peptide sequence. The corresponding
homology reduction should be either sequence-based or window-
based. Otherwise, it will overestimate the performance of the
prediction model as well. Therefore, window-based homology
reduction was applied in our case. Homology reductions within
positive and negative datasets were performed with similarity
threshold 70% between any two peptide sequences. Thus, 216
positives and 1980 negatives for arginine as well as 188 positives
and 2157 negatives for lysine were obtained, respectively.
The size of the refined, non-redundant negative datasets is much
larger than that of positive training datasets, which will result in bias
prediction infavorofnegativedata. Although manyapproachescan
be exploited to solve the imbalanced machine learning issues,
under-sampling used in previous works [9,10] was employed to
overcome the imbalance between positive and negative datasets
withthe optimal reductionofnegative datato 3 times the number of
positive data in present study after trials of different ratios, which
retains the original distribution of negative examples in order to
avoid loosing diversity information as possible. Thus, the final
negative training datasets contain 648 peptide sequences for
arginineand 564 peptide sequences for lysine withpeptide sequence
length 11. The resulting negative datasets and positive datasets were
pooled as the final training datasets and randomly split into 5
subsets,whichshareapproximatelyequalnumberofitemsfor5-fold
cross-validation training.
Bi-profile Bayes for feature extraction
Suppose that we have an unlabeled sample
S~ s1,s2,s3,   ,sn fg which denotes peptide sequence in our case,
where each sj j~0,1,   ,n ðÞ stands for one amino acid and n
represents the length of peptide sequence, i.e. the size of sliding
window in this study. S belongs to one of two categories C1 or
C{1, where C1 and C{1 represent methylated sites (positive data)
and non-methylated sites (negative data), respectively. According
to Bayes’ rule, the posterior probability of S for these two
categories can be given by
Pc 1 S j ðÞ ~
PSc 1 j ðÞ Pc 1 ðÞ
PS ðÞ
ð1Þ
Pc {1 S j ðÞ ~
PSc {1 j ðÞ Pc {1 ðÞ
PS ðÞ
ð2Þ
where Pc 1 ðÞ and Pc {1 ðÞ denote the prior probability for each
category. Assume that sj j~1,2,3,   ,n ðÞ are mutually indepen-
dent, Formula (1) and (2) can be rewritten as
PSc 1 j ðÞ ~ P
n
j~1
Ps j c1 j
  
ð3Þ
PSc {1 j ðÞ ~ P
n
j~1
Ps j c{1 j
  
ð4Þ
By the above, Formulas (1) and (2) can be reformulated as
log Pc 1 S j ðÞ ðÞ ~
X n
j~1
log Ps j c1 j
     
{log PS ðÞ ðÞ zC1 ð5Þ
log Pc {1 S j ðÞ ðÞ ~
X n
j~1
log Ps j c{1 j
     
{log PS ðÞ ðÞ zC2 ð6Þ
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function can be represented by formula (7)
fS ðÞ ~sgn log Pc 1 S j ðÞ ðÞ {log Pc {1 S j ðÞ ðÞ ðÞ ð 7Þ
Assume that prior distribution of category is uniform, namely,
Pc 1 ðÞ ~Pc {1 ðÞ , Formula (7) can be rewritten as
fS ðÞ ~sgn
X n
j~1
log Pa j c1 j
     
{
X n
j~1
log Pa j c{1 j
     
 !
ð8Þ
Formula (8) can further be formulated as
fS ðÞ ~sgn ~ w w.~ p p ðÞ ð 9Þ
where ~ w w~ w1,w1,   ,wn,wnz1,   ,w2n ðÞ is weigh vector,
~ p p~ p1,p2,   ,pn,pnz1,   ,p2n ðÞ is the posterior probability vector.
With respect to training sample S, fS ðÞ ~1 corresponds to class
C1 and fS ðÞ ~{1 to class C{1. In this study, p1,p2,   pn
represents the posterior probability of each amino acid at each
position in positive peptide sequence datasets (category C1)
(positive feature space)and pnz1,   ,p2n represents that in negative
peptide sequence datasets (category C{1) (negative feature space),
which we call Bi-profile. The posterior probability can be
estimated by the occurrence of each amino acid at each position
in training datasets, which we define as position-specific profile.
Profile generation and coding scheme
Two position-specific profiles for final model training, positive
position-specific profiles and negative position-specific profiles,
were generated through calculating the frequency of each amino
acid at each position in the positive datasets and negative datasets,
respectively. With respect to 5-fold cross-validation, position-
specific profiles were produced based on the above-mentioned
datasets minus the corresponding validation subset in each of five
rounds of training in order to avoid overestimation of the
performance. Through Bi-profile Bayes, each peptide sequence
(positive or negative peptide sequence) can be represented and
encoded by vector ~ p p~ p,p2,   ,pn,pnz1,   ,p2n ðÞ , simultaneously
containing positive and negative information, the dimension of
which is two times that of sliding window.
Support vector machines (SVMs) implementation and
parameter optimization
In this contribution, prediction model was trained and built with
LIBSVM package [11]. SVM is based on the structural risk
minimization principle from statistical learning theory [12], which
has been comprehensively applied to classification. With regard to
binary classification, the SVM trains a classifier by mapping the
input samples onto a high-dimensional space through kernel
functions, and then seeking a separating hyperplane that
differentiates the two classes with maximal margin and minimal
error.
Radial basis kernel function KS i,Sj
  
~exp {c Si{Sj
       2   
was selected for our SVM prediction system. Several preliminary
trials were made on input window size for prediction model with 5,
7, 9, 11, 13, 15, 17 (sliding window size) amino acid peptide
sequences centered by arginine and lysine. SVM parameter c and
penalty parameter C were optimized based on 5-fold cross-
validation in a grid-based manner with respect to the above
different length peptide sequences.
Performance assessments
Accuracy (Acc), Specificity (Sp), Sensitivity (Sn), Receiver
Operating Characteristic (ROC) curve, the area under ROC curve
(AUC) and Matthews Correlation Coefficient (MCC) were utilized
to assess the performance of prediction system. Acc denotes the
percentage of both positive instances (methylated sites) and
negative instances (non-methylated sites) correctly predicted.
Sensitivity (true positive rate) and Specificity (true negative rate)
represent the percentage of positive instances (methylated sites)
correctly predicted and that of negative instances (non-methylated
sites) correctly predicted, respectively. Due to the fact that
calculation of Sn and Sp at a single threshold is potentially
misleading, ROC cures is plotted to evaluate performance. A
ROC curve is a plot of Sensitivity versus (1-Specificity) and
generated by shifting the decision threshold. AUC gives a measure
of classifier performance. An AUC of 1.0 indicates perfect classifier
whereas an AUC of classifier no better than random is 0.5. The
MCC is used in machine learning as a measure of the quality of
binary classifications. It takes into account true and false positives
and negatives and is generally regarded as a balanced measure
which can be used even if the classes are of very different sizes. It
returns a value between 21 and +1. A coefficient of +1 represents
a perfect prediction, 0 an average random prediction and 21 the
worst possible prediction. All of the above measurements were
calculated in the case of 5-fold cross-validation and defined as
follows:
Acc~
TPzTN
TPzFPzTNzFN
, Sp~
TN
TNzFP
, Sn~
TP
TPzFN
,
MCC~
TP|TN ðÞ { FN|FP ðÞ
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
TPzFN ðÞ | TNzFP ðÞ | TPzFP ðÞ | TNzFN ðÞ
p
ð10Þ
where TP, TN, FP and FN denotes the number of true positives,
true negatives, false positives and false negatives, respectively.
Results
Performance of BPB-PPMS
The optimal parameters combination used for training model is
shown in Table 1. All of the results were calculated based on the
threshold value 0.5. The pooled datasets of positive training
datasets and negative training datasets were randomly divided into
five subsets with approximately equal number for cross-validation
training. BPB-PPMS achieves the performance with a sensitivity of
74.71%, a specificity of 94.32% and an accuracy of 87.98% for
arginine as well as a sensitivity of 70.05%, a specificity of 77.08%
and an accuracy of 75.51% in the case of 5-fold cross-validation.
To further evaluate the prediction performance, Receiver
operating characteristic (ROC) [13] curves were plotted for the
assessment of the performance of prediction models. The average
AUC is 0.9254 for arginine and 0.8383 for lysine (Red curves in
Figure 1 and Figure 2), respectively.
Comparison with Naı ¨ve Bayes and simple SVMs classifiers
Typically, two strategies can be employed to perform standard
comparison between distinct machine learning prediction models
for binary classification problems, either through cross-validation
experiments or test on the independent datasets given the same
threshold value. It is logical for cross-validation performance
comparison only when the training datasets for the prediction
model is identical to each other. With respect to the independent
test, the datasets employed should be not included into training
datasets as well as no homologous to training datasets. As
Predicting Protein Methylation
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PPMS is not identical to previous works [7,9]. Therefore, cross-
validation performance comparison between BPB-PPMS and
previous works [7,9] under the uniform framework is infeasible
and meaningless. Therefore, in order to evaluate the BPB-PPMS
in the case of cross-validation circumstance, both Naı ¨ve Bayes
classifier [14] and simple SVMs classifier s[11] without Bi-profile
Bayes feature extraction were developed to identify potential
protein methylation sites on the same training datasets as that of
BPB-PPMS. Naı ¨ve Bayes classifier calculates the probability that a
given example belongs to a certain class, which is based on the
assumption that the features representing the example are
conditionally independent given the class. Given an example S,
described by its feature vector s1,s2,s3,   ,sn ðÞ , we are looking for
a class C that maximizes the likelihood PSC j ðÞ ~
Ps 1,s2,s3,   ,sn C j ðÞ . The assumption of conditional indepen-
dence among the features, given the class, allows us to express this
conditional probability PSC j ðÞ as a product of probabilities
PSC j ðÞ ~ P
n
i~1
ps i C j ðÞ . Naı ¨ve Bayes classifier was trained using the
input features produced from positive position-specific profile for
positive training examples and negative position-specific profile for
negative training examples (see Methods section for further details)
through single feature space coding scheme, which was imple-
mented via the package downloaded from http://fuzzy.cs.
uni-magdeburg.de/,borgelt/bayes.html.
The principle of simple SVMs was briefly described in Methods
section. simple SVMs classifier was trained through binary
encoding for training samples and built with RBF kernel in
LIBSVM package[11]. Both classifiers were evaluated via the
same 5-fold cross-validation procedure as BPB-PPMS. All the
performances were assessed under the circumstance of the same
threshold value 0.5 and summarized in Table 2. The ROC
curves for the assessment of the performance of three classifiers
were plotted in Figure 1 and Figure 2. The value of AUC is
larger, the performance of model is better. As shown in Figure 1,
red, blue, and green curve denotes 5-fold cross-validation
prediction performance of Bi-profile Bayes SVM classifier, Simple
SVM classifier and Naı ¨ve Bayes classifier for arginine methylation,
respectively, the corresponding average AUC of which is 0.9254,
0.8958 and 0.8909, respectively. Likewise, red, blue, and green
curve in Figure 2 denotes 5-fold cross-validation prediction
performance of Bi-profile Bayes SVM classifier, Simple SVM
Figure 1. ROC curves to assess the prediction performance of
three arginine prediction models. Red, blue, and green curve
denotes 5-fold cross-validation prediction performance of Bi-profile
Bayes SVM classifier, Simple SVM classifier and Naı ¨ve Bayes classifier,
respectively. (The corresponding average AUC is 0.9254, 0.8958 and
0.8909, respectively.)
doi:10.1371/journal.pone.0004920.g001
Figure 2. ROC curves to assess the prediction performance of
lysine prediction model. Red, blue, and green curve denotes 5-fold
cross-validation prediction performance of Bi-profile Bayes SVM
classifier, Simple SVM classifier, Naı ¨ve Bayes classifier, respectively.
(The corresponding average AUC is 0.8383, 0.7498 and 0.7581,
respectively.)
doi:10.1371/journal.pone.0004920.g002
Table 1. The optimal parameters and performance of BPB-PPMS.
Methylated
residues Optimal parameters Performance
Sliding window
size
(a)
Type of
Kernel C
(c) c
(d) Sensitivity (%) Specificity (%) Accuracy (%) AUC
(e) (%) MCC
(f)
Arginine 11 RBF
(b) 32 0.5 74.71 94.32 87.98 92.54 0.7729
Lysine 11 RBF 128 8 70.05 77.08 75.51 83.83 0.3400
The optimal parameter combination was determined in a grid-based manner introduced in LIBSVM packages[11].
(a)Here, input window size for SVMs is two times sliding window size.
(b)RBF, Radial Basis Function KS i,Sj
  
~exp {c Si{Sj
       2   
.
(c)C, the penalty parameter of the error term in objective function.
(d)c, the parameter in Radial Basis Function.
(e)AUC, the area under ROC.
(f)MCC, Matthews Correlation Coefficient.
doi:10.1371/journal.pone.0004920.t001
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the corresponding average AUC of which is 0.8383, 0.7498 and
0.7581, respectively. All the compared results obtained from
Table 2, Figure1, and Figure 2 suggest that PBK-PPMS
outperformes Simple SVM classifier, Naı ¨ve Bayes classifier as well
as Bi-profile encoding scheme is better than single feature space or
binary coding scheme.
Comparison with previous works
Due to the absence of online server for the work done by Daily
et al[7], efforts were just made to compare the performance
between BPB-PPMS and MeMo. As mentioned in previous part,
cross-validation performance comparison between BPB-PPMS
and previous works [7,9] under the uniform framework is
infeasible and meaningless. With respect to independent dataset
comparison, it’s intractable to collect independent test datasets for
both BPB-PPMS and MeMo since there is no any information
regarding training datasets of MeMo for us. Therefore, unbiased
comparison between BPB-PPMS and MeMo is infeasible as well.
However, there is an attempt to further assess the performance of
BPB-PPMS through test on the independent datasets, which were
obtained by randomly choosing proteins with experimentally
verified arginine and lysine methylation as well as non-homolog to
those proteins used for training BPB-PPMS in PubMed literatures.
The final random independent test datasets consist of 21
methylated lysines on 18 proteins as well as 12 methylated
arginines on 11 proteins in the rat lumbar spinal cord[15] plus
three methylated arginines which was most recently found in
p53[16]. All of lysine methylation proteins and arginine methyl-
ation proteins were submitted to BPB-PPMS and MeMo. The
performance based on the prediction results were summarized in
Table 3. As shown in Table 3, the performance of MeMo is
measured with a sensitivity of 20.00%, a specificity of 88.42% for
arginine methylation proteins and a sensitivity of 9.52%, a
specificity of 92.47% for lysine methylation proteins. BPB-PPMS
achieves a sensitivity of 60.00%, with a specificity of 81.74% for
arginine methylation proteins as well as a sensitivity of 71.43%,
with a specificity of 91.51% for lysine methylation proteins at
threshold value 0.5. Performance comparisons were performed at
equivalent sensitivity or specificity value as a result of the absence
of threshold choice on MeMo server. Therefore, attempt was
made to adjust the threshold values of BPB-PPMS in order to
obtain equivalent sensitivity or specificity value of MeMo. As for
lysine methylation proteins, BPB-PPMS achieves a specificity of
98.65% compared to MeMo’s 92.74% specificity at the identical
sensitivity value 9.25% when the threshold value was set at 0.75.
With respect to arginine methylation, BPB-PPMS is measured by
a specificity of 88.56% and a sensitivity of 53.33% in the case of
threshold value 0.80. By comparison, MeMo achives sensitivity
value 20.00% at equivalent specificity of 88.42%.
One important question was advanced whether comparison
results shown in Table 3 could suggest that BPB-PPMS would
outperform MeMo since the independent test datasets is just in
terms of BPB-PPMS. Theoretically, it is logical that the
performance on datasets that are identical or homologous to
training datasets should be better than that on independent
datasets. Therefore, no matter whether independent datasets
collected in present study is independent of training datasets of
MeMo or not, it can be concluded that BPB-PPMS outperforms
MeMo, at least at above equivalent sensitivity or specificity.
Application of BPB-PPMS: a case study
Human immunodeficiency virus type 1 (HIV-1) Tat protein is a
key player in HIV replication by virtue of its ability to dramatically
increase gene transcription efficiency from the 59 long terminal
repeat (LTR) of the viral DNA[17]. The rate of transcription of
Table 2. Comparison among Naı ¨ve Bayes classifier, simple SVM classifier and BPB-PPMS classifier in the 5-fold cross-validation
experiment on the same training datasets.
Methods Methylated residues Sensitivity (%) Specificity (%) Accuracy (%) MCC
Naı ¨ve Bayes Arginine 67.82 85.35 79.68 0.5379
Lysine 66.31 73.19 71.62 0.2755
simple SVM Arginine 70.11 89.01 82.90 0.6248
Lysine 65.24 71.78 70.32 0.2502
BPB-PPMS Arginine 74.71 92.46 86.80 0.7243
Lysine 70.05 77.08 75.51 0.3400
doi:10.1371/journal.pone.0004920.t002
Table 3. Performance of BPB-PPMS and MeMo on independent test datasets in terms of BPB-PPMS.
Server Methylated residues Threshold* Sensitivity (%) Specificity (%) Accuracy (%)
MeMo Arginine - 20.00 88.42 87.22
Lysine - 9.52 92.47 91.11
BPB-PPMS Arginine 0.5 60.00 81.74 81.36
0.8 53.33 88.56 87.96
Lysine 0.5 71.43 91.51 91.19
0.75 9.52 98.65 97.19
*Prediction threshold value is not avalable in MeMo.
doi:10.1371/journal.pone.0004920.t003
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viral protein Tat with the LTR and other transcriptional
machinery [18]. Such specific interactions can be affected by the
state of post-translational modifications on Tat. Tat protein is not
included in our training datasets and can be employed for a case
study
Recent studies[1,19,20] have shown that Tat can be specifically
methylated by protein arginine methyltransferases 6 (PRMT6) on
arginine residues at positions 52 and 53, resulting in a decreased
interaction with TAR and cyclin T1 complex formation, therefore
decreasing HIV-1 transcriptional activation. In order to map the
region of Tat that is methylated by PRMT6, Boulanger et al [19]
obtained three peptides that cover all the arginines of Tat. Tat
peptide 1–14 contains arginine 7, peptide 49–63 contains the
arginine-rich motif, and peptide 69–83 contains arginine 78. The
findings obtained from in vitro methylation assays using these three
Tat peptides demonstrate that Tat is methylated at region 49–63.
Mutational analysis in another work done by Xie et al [1] was
performed specifically on the 49-RKKRR-53 stretch, demonstrat-
ing that both R52 and R53 are targets for methylation. Our BPB-
PPMS server predicts that arginine methylation of Tat can
potentially occur at the site R7,R47,R52 and R53.
Most recently, Duyne et al [20] investigated the methylation of
lysines on the peptide 45-ISYGRKKRRQ-54 of Tat. In vitro
methylation assays show that lysine 50 and lysine 51 can be
methylated by histone methyltransferases SETDB1, the SUV39-
family of SET-domain containing proteins. They proposed that
the methylation of Tat lysine 50 and 51 can result in a decrease in
viral transcription. Our BPB-PPMS server predicts that there are
two potentially methylated lysine sites K50, K51 on Tat with the
probability 0.838290 and 0.8500, respectively. The prediction
results regarding lysine methylation status on Tat are exactly in
agreement with those obtained from experiments done by Duyne
et al [20].
To verify whether these results to some extent reflect the
generalization ability and robustness of BPB-PPMS, we checked
the similarity among the positive training examples and peptide
sequences including four experimentally verified methylated
arginines and lysines. Interestingly, the maximum similarity with
examples in positive training datasets is 40% for ISYGRK(50)
KRRQR, 50% for SYGRKK (51) RRQRR, 70% for
YGRKKR(53) RQRRR and 70% for GRKKRR(54) QRRRP,
respectively. Therefore, it can be concluded that the results from
Tat protein study, to some extent, verify the generalization ability
of BPB-PPMS. The detailed prediction results on Tat protein
through three classifiers are shown in Table 4.
Discussion
In this work, a novel online tool (BPB-PPMS) was developed to
predict arginine and lysine methylation sites from sequences using
Bi-profile Bayes feature extraction combined with SVMs. Results
from cross-validation experiments (Table 2) indicate that BPB-
PPMS outperforms both Naı ¨ve Bayes and simple SVMs classifiers
due to the fact that Bi-profile Bayes coding scheme possesses
advantages over binary coding scheme and single feature space
coding scheme. In addition, performance on independent datasets
for BPB-PPMS and MeMo (Table 3) shows that BPB-PPMS
outperforms MeMo, even though independent datasets is only in
terms of BPB-PPMS, which might result from two factors. One is
the more diverse training datasets employed in BPB-PPMS
(training datasets collected up to Sep, 2008) than those used in
MeMo (training datasets collected before submission of MeMo
work, Jan-19, 2006). Another factor is that, as indicated by
Table 2, Bi-profile Bayes coding scheme used in BPB-PPMS
outperforms binary coding scheme utilized by MeMo.
Prediction models for functional sites can provide valuable
information for future experimental designs. However, informa-
tion regarding negative training/test datasets (definitely deter-
mined non-functional sites) is scarce, which is a choke point for the
development of prediction models. Most of the existing tools
(classifiers) for prediction of PTM sites from sequences[7,9,10,21]-
were developed through various kinds of machine learning
approaches using experimentally verified PTM sites and putative
non-PTM sites as training datasets. The performance of classifiers
not only depends on the robustness of machine learning
approaches, but also whether the features extracted from training
datasets accurately reflect those of PTMs or non-PTMs.
Therefore, the quality of training datasets directly influences the
classification boundary and subsequent prediction performance.
The putative negative examples employed in most of prediction
models are generated based on either features of known functional
sites[14] or ‘‘accept or reject’’ rule[7,9,10]. A recent study[22]
proposed maximum distance minimum redundancy approach to
generate initial negative training datasets and predicted non-
coding RNAs from unlabeled data, which may be an useful way
for the generation of negative training examples with high
confidence and could be extended to the investigation of PTM
site prediction modeling. Although it is to some extent rational for
the generation of putative negative training examples (non-PTM
sites) from all of the remaining sites on proteins containing
experimentally verified sites (methylated arginines and lysines in
our case)[7,9,10], some putative negative examples are in fact
false, which will contribute to false negative prediction. Therefore,
as more validated methylated sites from high throughput
proteomic experiments become available, it should be possible to
further improve the reliability of predictions. In addition, the
inclusion of structural information into modeling process could be
another way to enhance the prediction performance since
methylation is an enzymatic process and the interactions between
methylated sites and enzymes concerned should be structurally
satisfied.
Table 4. Potential methylation sites predicted on Tat protein (P04610) through BPB-PPMS, Simple SVMs, and Naı ¨ve Bayes
classifiers.
Experimentally verified
methylation sites on Tat protein Potential methylation sites predicted on Tat protein
BPB-PPMS Simple SVMs Naı ¨ve Bayes
K50,K51,R52,R53 K50(0.83829), K51(0.8500), R7(0.992805), R49
(0.917059), R52(0.991765), R53(0.941735)
K28(0.9012), K50 (0.889106),
K71(0.7622), R53(0.78301)
K19 (0.6577), K50(0.9250),
K71(0.8119233)
The numbers in bracket denote the predictive probability of methylation at corresponding sites.
doi:10.1371/journal.pone.0004920.t004
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